Diabetes Technology and Therapeutics
Journal Impact IF - Analysis · Trend · Prediction · Ranking
Journal Impact IF
2019-2020
4.403
Journal Impact IF Trend
Diabetes Technology and Therapeutics
The 2019-2020 Journal Impact IF of Diabetes Technology and Therapeutics is 4.403, which is just updated in 2020.
The highest Journal Impact IF of Diabetes Technology and Therapeutics is 4.488.
The lowest Journal Impact IF of Diabetes Technology and Therapeutics is 1.931.
The total growth rate of Diabetes Technology and Therapeutics IF is 128.0%.
The annual growth rate of Diabetes Technology and Therapeutics IF is 14.2%.
Journal Impact IF Ranking
| Subcategory | Quartile | Rank | Percentile |
|---|---|---|---|
| Medical Laboratory Technology | Q1 | 2/28 |
Medical Laboratory Technology 94% |
| Endocrinology, Diabetes and Metabolism | Q1 | 26/217 |
Endocrinology, Diabetes and Metabolism 88% |
| Endocrinology | Q1 | 17/118 |
Endocrinology 86% |
· In the Medical Laboratory Technology research field, the Quartile of Diabetes Technology and Therapeutics is Q1. Diabetes Technology and Therapeutics has been ranked #2 over 28 related journals in the Medical Laboratory Technology research category. The ranking percentile of Diabetes Technology and Therapeutics is around 94% in the field of Medical Laboratory Technology.
Diabetes Technology and Therapeutics Key Factor Analysis
· In the Endocrinology, Diabetes and Metabolism research field, the Quartile of Diabetes Technology and Therapeutics is Q1. Diabetes Technology and Therapeutics has been ranked #26 over 217 related journals in the Endocrinology, Diabetes and Metabolism research category. The ranking percentile of Diabetes Technology and Therapeutics is around 88% in the field of Endocrinology, Diabetes and Metabolism.
Diabetes Technology and Therapeutics Key Factor Analysis
· In the Endocrinology research field, the Quartile of Diabetes Technology and Therapeutics is Q1. Diabetes Technology and Therapeutics has been ranked #17 over 118 related journals in the Endocrinology research category. The ranking percentile of Diabetes Technology and Therapeutics is around 86% in the field of Endocrinology.
Diabetes Technology and Therapeutics Key Factor Analysis
Related Journals
International Collaboration Trend
Cited Documents Trend
Journal Impact IF History
| Year | Journal Impact IF |
|---|---|
| Year | Journal Impact IF |
| 2019-2020 | 4.403 |
| 2018-2019 | 4.488 |
| 2017-2018 | 2.921 |
| 2016-2017 | 2.698 |
| 2015-2016 | 2.198 |
| 2014-2015 | 2.106 |
| 2013-2014 | 2.293 |
| 2012-2013 | 2.205 |
| 2011-2012 | 1.931 |
· The 2019-2020 Journal Impact IF of Diabetes Technology and Therapeutics is 4.403
Diabetes Technology and Therapeutics Key Factor Analysis
· The 2018-2019 Journal Impact IF of Diabetes Technology and Therapeutics is 4.488
Diabetes Technology and Therapeutics Key Factor Analysis
· The 2017-2018 Journal Impact IF of Diabetes Technology and Therapeutics is 2.921
Diabetes Technology and Therapeutics Key Factor Analysis
· The 2016-2017 Journal Impact IF of Diabetes Technology and Therapeutics is 2.698
Diabetes Technology and Therapeutics Key Factor Analysis
· The 2015-2016 Journal Impact IF of Diabetes Technology and Therapeutics is 2.198
Diabetes Technology and Therapeutics Key Factor Analysis
· The 2014-2015 Journal Impact IF of Diabetes Technology and Therapeutics is 2.106
Diabetes Technology and Therapeutics Key Factor Analysis
· The 2013-2014 Journal Impact IF of Diabetes Technology and Therapeutics is 2.293
Diabetes Technology and Therapeutics Key Factor Analysis
· The 2012-2013 Journal Impact IF of Diabetes Technology and Therapeutics is 2.205
Diabetes Technology and Therapeutics Key Factor Analysis
· The 2011-2012 Journal Impact IF of Diabetes Technology and Therapeutics is 1.931
Diabetes Technology and Therapeutics Key Factor Analysis
About
Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and each issue highlights new pharmacological and device developments to optimize patient care.
The ISSN of Diabetes Technology and Therapeutics is
1520-9156
.
An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.
Diabetes Technology and Therapeutics Key Factor Analysis
The ISSN (Online) of Diabetes Technology and Therapeutics is
1557-8593
.
An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.
Diabetes Technology and Therapeutics Key Factor Analysis
Diabetes Technology and Therapeutics is published by
Mary Ann Liebert Inc.
.
Diabetes Technology and Therapeutics Key Factor Analysis
Diabetes Technology and Therapeutics publishes reports
Bimonthly
.
Diabetes Technology and Therapeutics Key Factor Analysis
The Publication History of Diabetes Technology and Therapeutics covers
1999 - Present
.
Diabetes Technology and Therapeutics Key Factor Analysis
Diabetes Technology and Therapeutics is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers.
Diabetes Technology and Therapeutics Key Factor Analysis
There is no publication fee for submiting manuscript to Diabetes Technology and Therapeutics. Diabetes Technology and Therapeutics is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles.
Diabetes Technology and Therapeutics Key Factor Analysis
The language of Diabetes Technology and Therapeutics is
English
.
Diabetes Technology and Therapeutics Key Factor Analysis
The publisher of Diabetes Technology and Therapeutics is
Mary Ann Liebert Inc.
,
which locates in
United States
.
Diabetes Technology and Therapeutics Key Factor Analysis
Popular Journals
What is Impact Factor?
The impact factor (IF) is frequently used as an indicator of the importance of a journal to its field. It was first introduced by Eugene Garfield, the founder of the Institute for Scientific Information. Although IF is widely used by institutions and clinicians, people have widespread misconception regarding the method for calculating the journal IF, its significance and how it can be utilized. The IF of a journal is not associated to the factors like quality of peer review process and quality of content of the journal, but is a measure that reflects the average number of citations to articles published in journals, books, thesis, project reports, newspapers, conference/seminar proceedings, documents published in internet, notes, and any other approved documents.
Impact factor is commonly used to evaluate the relative importance of a journal within its field and to measure the frequency with which the “average article” in a journal has been cited in a particular time period. Journal which publishes more review articles will get highest IFs. Journals with higher IFs believed to be more important than those with lower ones. According to Eugene Garfield “impact simply reflects the ability of the journals and editors to attract the best paper available.” Journal which publishes more review articles will get maximum IFs. The Journal Impact of an academic journal is a scientometric Metric that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a Metric for the relative importance of a journal within its field; journals with higher Journal Impact are often deemed to be more important than those with lower ones. The Diabetes Technology and Therapeutics Journal Impact IF measures the average number of citations received in a particular year (2020) by papers published in the Diabetes Technology and Therapeutics during the two preceding years (2018-2019). Note that 2020 Journal Impact are reported in 2021; they cannot be calculated until all of the 2020 publications have been processed by the indexing agency. In addition to the 2-year Journal Impact, the 3-year Journal Impact can provide further insights and factors into the impact of Diabetes Technology and Therapeutics.